Abstract
Introduction Contrary to North America and Europe, the prevalence of hypertension is rising in West Africa. With a transition from whole foods to processed foods in Nigeria, diet plays a key driver of hypertension. To combat this, the national nutritional guidelines in Nigeria were implemented, but their translation into actionable tools for clinicians remains a challenge. Currently, there are no simple dietary assessment tools that are concise and suitable to be incorporated into clinical care without requiring extensive data analysis while still providing personalised dietary support to their patients. This study aims to deliver a clinically tested and validated short dietary assessment tool for clinicians, patients, and researchers across Nigeria to provide personalised dietary advice for patients with hypertension.
Methods The study will be conducted in two phases: Phase 1 (n=75) will investigate the feasibility of the short FFQ and its agreement with 24-hour dietary recalls (3x) in a clinical setting in Nigeria. During the analysis of Phase 1 data, a scoring system will be developed based on the associations between individual food items in the FFQ and measures of hypertension. Phase 2 (n=50) will assess the acceptability of the FFQ and validate the association between the FFQ score and hypertension.
Expected outcomes The development of a clinically tested and validated short food frequency questionnaire that will be ready to use by clinicians, patients, and researchers across Nigeria to support the prevention and management of hypertension.
Conclusion This study will contribute to knowledge on dietary assessment and hypertension prevention by developing a validated and acceptable FFQ, which will be valuable for clinicians and researchers for personalised dietary recommendations to combat hypertension in Nigeria. Keywords: West Africa, diet, food, LMIC, blood pressure.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ClinicalTrials.gov: NCT05973760.
Clinical Protocols
https://www.clinicaltrials.gov/study/NCT05973760?term=NCT05973760&rank=1
Funding Statement
This study was funded by the Tertiary Education Trust Fund (TETFund) of Nigeria (https://tetfund.gov.ng/) and it was awarded to NPB.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval has been carefully addressed in this study, as evidenced by the approval from the following ethics boards. Business, Earth & Environment, Social Sciences (AREA FREC) Committee, University of Leeds, Leeds, United Kingdom, approved with the number: AREA FREC 2023-0484-572 on 28/04/2023. Similarly, the Rivers State University Teaching Hospital Research Ethics Committee in Port Harcourt, Nigeria, approved the number: RSUTH/REC/2023316 on 30/03/2023.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding: This study was funded by the Tertiary Education Trust Fund (TETFund) of Nigeria. MAZ is currently funded by Wellcome Trust (217446/Z/19/Z). The funders do not have any role in any aspect of this study.
Competing interests: There are no conflicts of interest.
Roles and Responsibilities Authors: NPB wrote and drafted the protocol, while NPB and MAZ collaborated on the research methodology design. JBM and MAZ played significant roles in reviewing and revising the protocol.
Data Availability
No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.
